BioCentury
ARTICLE | Financial News

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

December 17, 2019 11:23 PM UTC
Updated on Dec 17, 2019 at 11:32 PM UTC

Lilly releases full-year 2020 guidance
Eli Lilly and Co. (NYSE:LLY) expects adjusted EPS of $6.70-$6.80 on revenues of $23.6-$24.1 billion in 2020, according to new guidance released Tuesday. Both ranges reflect growth expected from its current expectations of adjusted EPS of $5.75-$5.85 on $22-$22.5 billion in revenues in 2019, and exceed analysts' consensus estimates of $6.62 on $23.5 billion in revenues in 2020, according to FactSet.

JOINN raises $60M series A
JOINN Biologics Inc. raised $60 million in a series A round led by Huagai Capital with participation by Nestbio Capital, Hong Kong Linkage Holdings and Xiangtang Capital. The CDMO will use the funding to expand production capacity in China and expand its business in U.S. and China...